Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah W Bruner

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2017
Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapyMatthew J Ferris, Jim Zhong, Jeffrey M Switchenko, et al.
Journal of Pain and Symptom Management|December 1, 2016
Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG ModificationStephanie L Pugh, Gwen Wyatt, Raimond K W Wong, et al.
Cancer|May 24, 2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studyCanhua Xiao, Jonathan J Beitler, Gang Peng, et al.
JAMA Oncology|February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical TrialDeborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient SurvivalRonald C Eldridge, Karan Uppal, D Neil Hayes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
JAMA Oncology|March 16, 2018
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical TrialJeff M Michalski, Jennifer Moughan, James Purdy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2017
Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapyMatthew J Ferris, Jim Zhong, Jeffrey M Switchenko, et al.
Journal of Pain and Symptom Management|December 1, 2016
Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG ModificationStephanie L Pugh, Gwen Wyatt, Raimond K W Wong, et al.
Cancer|May 24, 2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studyCanhua Xiao, Jonathan J Beitler, Gang Peng, et al.
JAMA Oncology|February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical TrialDeborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient SurvivalRonald C Eldridge, Karan Uppal, D Neil Hayes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
Pageof 9